secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-206806
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA files new S-3ASR; $156.6M ATM capacity remains under Jefferies agreement
-------------------------------------------------------------------------------

- Filed new automatic shelf registration (S-3ASR) to replace expiring June 2026 shelf; effective May 5, 2026.
- Prior sales under ATM totaled $193.4M gross proceeds; remaining capacity of $156.6M under same Sales Agreement.
- ATM prospectus supplement filed for at-the-market stock sales via Jefferies; no change in terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312526206806/0001193125-26-206806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312526206806/d949251d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-206806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer